Krystal Biotech Inc
KRYS240.800USD
+7.430+3.18%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
6.98BMarket Cap
34.91P/E TTM
More Details of Krystal Biotech Inc Company
Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. The Company is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include KB407, KB408, KB707, KB105, KB801, KB803, KB304 and KB301. Its commercial product, VYJUVEK, is a redosable gene therapy, and a genetic medicine approved in the United States and Europe for the treatment of dystrophic epidermolysis bullosa. KB407 is being developed for the treatment of Cystic Fibrosis. KB408 is being developed for the treatment of Alpha-1 Antitrypsin Deficiency, a rare lung disease. KB707 is being developed for the treatment of solid tumors. KB105 is being developed for TGM1-Deficient Autosomal Recessive Congenital Ichthyosis. KB803 is a redosable eye drop formulation of B-VEC, designed for the treatment of ocular complications.
Krystal Biotech Inc Info
Ticker SymbolKRYS
Company nameKrystal Biotech Inc
IPO dateSep 20, 2017
CEOKrishnan (Krish S)
Number of employees275
Security typeOrdinary Share
Fiscal year-endSep 20
Address2100 Wharton St Ste 701
CityPITTSBURGH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code15203
Phone14125865830
Websitehttps://www.krystalbio.com/
Ticker SymbolKRYS
IPO dateSep 20, 2017
CEOKrishnan (Krish S)
Company Executives of Krystal Biotech Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Krish S. Krishnan
Mr. Krish S. Krishnan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.62M
-1.82%
Ms. Suma M. Krishnan
Ms. Suma M. Krishnan
President - Research and Development, Founder, Director
President - Research and Development, Founder, Director
1.55M
-1.58%
Mr. Dino A. Rossi
Mr. Dino A. Rossi
Independent Director
Independent Director
78.69K
--
Dr. Adm. Christopher (Chris) Mason, M.D., Ph.D.
Dr. Adm. Christopher (Chris) Mason, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Kirti Ganorkar
Mr. Kirti Ganorkar
Independent Director
Independent Director
--
--
Mr. Daniel S. Janney
Mr. Daniel S. Janney
Lead Independent Director
Lead Independent Director
--
--
Ms. Catherine Mazzacco
Ms. Catherine Mazzacco
Independent Director
Independent Director
--
--
Dr. Everett Rand Sutherland, M.D.
Dr. Everett Rand Sutherland, M.D.
Independent Director
Independent Director
--
--
Mr. Julian S. Gangolli
Mr. Julian S. Gangolli
Independent Director
Independent Director
--
--
Ms. Meg Dodge
Ms. Meg Dodge
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Krish S. Krishnan
Mr. Krish S. Krishnan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.62M
-1.82%
Ms. Suma M. Krishnan
Ms. Suma M. Krishnan
President - Research and Development, Founder, Director
President - Research and Development, Founder, Director
1.55M
-1.58%
Mr. Dino A. Rossi
Mr. Dino A. Rossi
Independent Director
Independent Director
78.69K
--
Dr. Adm. Christopher (Chris) Mason, M.D., Ph.D.
Dr. Adm. Christopher (Chris) Mason, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Kirti Ganorkar
Mr. Kirti Ganorkar
Independent Director
Independent Director
--
--
Mr. Daniel S. Janney
Mr. Daniel S. Janney
Lead Independent Director
Lead Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Nov 21
Updated: Fri, Nov 21
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.95%
BlackRock Institutional Trust Company, N.A.
12.07%
The Vanguard Group, Inc.
9.61%
Avoro Capital Advisors LLC
9.58%
Krishnan (Krish S)
5.58%
Other
48.21%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.95%
BlackRock Institutional Trust Company, N.A.
12.07%
The Vanguard Group, Inc.
9.61%
Avoro Capital Advisors LLC
9.58%
Krishnan (Krish S)
5.58%
Other
48.21%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.56%
Investment Advisor/Hedge Fund
29.28%
Individual Investor
11.65%
Hedge Fund
8.97%
Private Equity
2.85%
Research Firm
1.95%
Pension Fund
1.09%
Sovereign Wealth Fund
1.00%
Bank and Trust
0.44%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
611
28.05M
96.74%
-1.59M
2025Q2
590
32.63M
112.75%
-1.09M
2025Q1
597
32.73M
113.26%
-1.18M
2024Q4
555
33.11M
114.98%
-1.88M
2024Q3
532
33.56M
116.82%
-1.97M
2024Q2
492
34.00M
119.08%
+2.68M
2024Q1
457
29.99M
105.21%
-815.24K
2023Q4
418
29.64M
105.24%
-696.04K
2023Q3
406
29.89M
107.26%
-297.23K
2023Q2
399
29.15M
106.30%
+625.16K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.33M
14.95%
+13.93K
+0.32%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.52M
12.16%
-115.65K
-3.18%
Jun 30, 2025
The Vanguard Group, Inc.
2.82M
9.74%
-2.39K
-0.08%
Jun 30, 2025
Avoro Capital Advisors LLC
2.66M
9.19%
-71.00K
-2.60%
Jun 30, 2025
Krishnan (Krish S)
1.65M
5.69%
-25.00K
-1.49%
Jul 16, 2025
Krishnan (Suma M)
1.58M
5.45%
-25.00K
-1.56%
Jul 16, 2025
State Street Investment Management (US)
1.36M
4.68%
+128.64K
+10.49%
Jun 30, 2025
Soleus Capital Management, L.P.
922.96K
3.19%
+481.20K
+108.93%
Jun 30, 2025
Capital World Investors
942.25K
3.26%
-12.22K
-1.28%
Jun 30, 2025
Frazier Life Sciences Management, L.P.
688.46K
2.38%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Franklin Genomic Advancements ETF
5.26%
First Trust NYSE Arca Biotechnology Index Fund
3.66%
Invesco S&P SmallCap Health Care ETF
3.12%
Clough Hedged Equity ETF
2.47%
Invesco S&P SmallCap 600 GARP ETF
2.31%
ALPS Medical Breakthroughs ETF
2.28%
Virtus LifeSci Biotech Products ETF
2.25%
State Street SPDR S&P Biotech ETF
2.07%
Invesco S&P SmallCap 600 Pure Growth ETF
1.54%
WisdomTree BioRevolution Fund
1.35%
View more
Franklin Genomic Advancements ETF
Proportion5.26%
First Trust NYSE Arca Biotechnology Index Fund
Proportion3.66%
Invesco S&P SmallCap Health Care ETF
Proportion3.12%
Clough Hedged Equity ETF
Proportion2.47%
Invesco S&P SmallCap 600 GARP ETF
Proportion2.31%
ALPS Medical Breakthroughs ETF
Proportion2.28%
Virtus LifeSci Biotech Products ETF
Proportion2.25%
State Street SPDR S&P Biotech ETF
Proportion2.07%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion1.54%
WisdomTree BioRevolution Fund
Proportion1.35%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Krystal Biotech Inc?
The top five shareholders of Krystal Biotech Inc are:
Fidelity Management & Research Company LLC holds 4.33M shares, accounting for 14.95% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.52M shares, accounting for 12.16% of the total shares.
The Vanguard Group, Inc. holds 2.82M shares, accounting for 9.74% of the total shares.
Avoro Capital Advisors LLC holds 2.66M shares, accounting for 9.19% of the total shares.
Krishnan (Krish S) holds 1.65M shares, accounting for 5.69% of the total shares.
Fidelity Management & Research Company LLC holds 4.33M shares, accounting for 14.95% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.52M shares, accounting for 12.16% of the total shares.
The Vanguard Group, Inc. holds 2.82M shares, accounting for 9.74% of the total shares.
Avoro Capital Advisors LLC holds 2.66M shares, accounting for 9.19% of the total shares.
Krishnan (Krish S) holds 1.65M shares, accounting for 5.69% of the total shares.
What are the top three shareholder types of Krystal Biotech Inc?
The top three shareholder types of Krystal Biotech Inc are:
Fidelity Management & Research Company LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Fidelity Management & Research Company LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
How many institutions hold shares of Krystal Biotech Inc (KRYS)?
As of 2025Q3, 611 institutions hold shares of Krystal Biotech Inc, with a combined market value of approximately 28.05M, accounting for 96.74% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -16.02%.
What is the biggest source of revenue for Krystal Biotech Inc?
In --, the -- business generated the highest revenue for Krystal Biotech Inc, amounting to -- and accounting for --% of total revenue.
